Digital Media briefs

Share this article:
HealthiNation named Doug McFarland chief digital officer. McFarland, a HealthiNation board member for two years, was recently co-CEO of Dimestore Media, acquired last year by KnowledgeNetwork. He will oversee digital strategy and operations activities at the health video firm.

Novartis announced plans to roll out an iPhone app for MS patients that will allow them mobile access to its patient support programs. In January, the company released VaxTrak, which allows patients and caregivers to track vaccinations on their iPhones.

The Interactive Advertising Bureau found a broad online advertising recovery under way, with first-half revenues up nearly 12% over the same period in 2009, Advertising Age reported. Companies spent $12.13 billion on online advertising in the first half, making it the biggest six-month total of online ad spending ever, said the title.

Boehringer Ingelheim and the Latino Commission on AIDS launched, a Spanish-language online resource for Latinos living with HIV, as well as the healthcare providers and health educators that tend to them. The site, said BI, aims to enhance HIV/AIDS care and treatment by fostering open dialogue about the disease.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?